MEIP

MEI Pharma, Inc. [MEIP] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MEIP Stock Summary

Top 10 Correlated Stocks

MEIP


In the News

01:32 11 Dec 2023 MEIP

All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy

MEI Pharma, Inc. (MEIP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

07:47 11 Dec 2023 MEIP

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript

MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2023 Earnings Call Transcript September 26, 2023 5:00 PM ET Company Participants David Walsey - SVP, Corporate Affairs David Urso - President & CEO Jay File - CFO Richard Ghalie - CMO Conference Call Participants Yale Jen - Laidlaw & Company Stephen Willey - Stifel Operator Good day and welcome to the MEI Fiscal Year-End Earnings Call. My name is Gary and I will be the conference facilitator today.

12:08 11 Dec 2023 MEIP

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming drug candidate, announced today that the companies will host a recorded joint video webcast that will be available at 8:00 am Eastern.

07:02 11 Dec 2023 MEIP

MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates

MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $2.32 per share versus the Zacks Consensus Estimate of a loss of $2.60. This compares to loss of $3.40 per share a year ago.

07:35 11 Dec 2023 MEIP

MEI Pharma, Inc. (MEIP) Q2 Earnings and Revenues Top Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 150% and 237.82%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

06:48 11 Dec 2023 MEIP

MEI Pharma, Inc. (MEIP) Reports Q1 Loss, Lags Revenue Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 10.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

09:00 11 Dec 2023 MEIP

MEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcript

MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2022 Results Conference Call September 8, 2022 5:00 PM ET Company Participants David Walsey - Senior Vice President and Corporate Affairs Dan Gold - President and Chief Executive Officer Brian Drazba - Chief Financial Officer David Urso - Chief Operating Officer and General Counsel Richard Ghalie - Chief Medical Officer Conference Call Participants Stephen Willey - Stifel Robyn Karnauskas - Truist Yale Jen - Laidlaw & Co Nick Abbott - Wells Fargo Operator Good afternoon, and welcome to the MEI Pharma 2022 Fiscal Year End Conference Call. Please be advised that the call is being recorded at the Company's request.

04:34 11 Dec 2023 MEIP

Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List

Can these penny stocks continue to make gains The post Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

07:20 11 Dec 2023 MEIP

Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now

Biotech penny stocks to watch in June. The post Top Penny Stocks To Buy?

06:49 11 Dec 2023 MEIP

MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 55.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

MEIP Financial details

Company Rating
Strong Buy
Market Cap
44.77M
Income
42.11M
Revenue
105.38M
Book val./share
12.21
Cash/share
12.34
Dividend
1.75
Dividend %
26.04%
Employees
46
Optionable
No
Shortable
Yes
Earnings
07 Feb 2024
P/E
1.06
Forward P/E
-1.37
PEG
-0.07
P/S
0.42
P/B
0.55
P/C
0.54
P/FCF
-0.8
Quick Ratio
9.6
Current Ratio
10.32
Debt / Equity
0.15
LT Debt / Equity
0.14
-
-
EPS (TTM)
6.32
EPS next Y
-4.89
EPS next Q
-1.52
EPS this Y
-52.39%
EPS next Y
-177.37%
EPS next 5Y
-146.04%
EPS last 5Y
-20.54%
Revenue last 5Y
58.27%
Revenue Q/Q
4381.61%
EPS Q/Q
-660.26%
-
-
-
-
SMA20
-9.75%
SMA50
-7.12%
SMA100
-10.25%
Inst Own
2.19%
Inst Trans
0%
ROA
42%
ROE
89%
ROC
0.4%
Gross Margin
100%
Oper. Margin
35%
Profit Margin
40%
Payout
-
Shs Outstand
6.66M
Shs Float
4.94M
-
-
-
-
Target Price
15
52W Range
4.0-7.97
52W High
-4%
52W Low
+68%
RSI
53.12
Rel Volume
0.59
Avg Volume
59.39K
Volume
34.9K
Perf Week
9.8%
Perf Month
-4.68%
Perf Quarter
-6.28%
Perf Half Y
-8.2%
-
-
-
-
Beta
0.697
-
-
Volatility
0.22%, 0.51%
Prev Close
-0.15%
Price
6.72
Change
1.36%

MEIP Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
4.416.357.427.477.33
Net income per share
-15.09-10.1-14.69-10.04-4.78
Operating cash flow per share
-26.47.52-9.29-8.94-7.88
Free cash flow per share
-26.597.33-9.49-9.03-7.88
Cash per share
66.8340.144.5828.1115.11
Book value per share
4317.1812.029.613.7
Tangible book value per share
42.7717.1812.029.613.7
Share holders equity per share
4317.1812.029.613.7
Interest debt per share
-51.1902.411.821.91
Market cap
56.18M376.16M196.19M66.51M43.84M
Enterprise value
46.59M363.83M195.94M60.41M39.66M
P/E ratio
-3.34-8.17-3.88-1.22-1.38
Price to sales ratio
11.4313.017.681.630.9
POCF ratio
-1.9110.98-6.14-1.36-0.84
PFCF ratio
-1.911.27-6-1.35-0.83
P/B Ratio
1.174.814.741.271.78
PTB ratio
1.174.814.741.271.78
EV to sales
9.4812.587.671.480.81
Enterprise value over EBITDA
-0.63-233.07-2.24-0.63-1.04
EV to operating cash flow
-1.5810.62-6.13-1.24-0.76
EV to free cash flow
-1.5710.9-6-1.23-0.76
Earnings yield
-0.3-0.12-0.26-0.82-0.73
Free cash flow yield
-0.530.09-0.17-0.74-1.2
Debt to equity
000.20.180.52
Debt to assets
000.050.050.11
Net debt to EBITDA
0.137.900.060.11
Current ratio
5.758.955.446.845.29
Interest coverage
0.8100-265.790
Income quality
1.75-0.740.630.91.65
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
2.970.580.960.750.68
Research and developement to revenue
6.571.182.722.11.07
Intangibles to total assets
00000
Capex to operating cash flow
0.01-0.030.020.010
Capex to revenue
-0.04-0.03-0.03-0.010
Capex to depreciation
-2.71-8.2-2.48-1.47-0.09
Stock based compensation to revenue
1.340.240.40.210.07
Graham number
120.8362.4963.0346.6119.93
ROIC
-0.96-0.31-1.2-1.06-0.62
Return on tangible assets
-0.2-0.22-0.29-0.31-0.26
Graham Net
39.2214.597.666.490.69
Working capital
67.9M185.34M134.52M142.68M87.19M
Tangible asset value
47.67M78.22M41.36M52.41M24.62M
Net current asset value
47.47M77.13M32.08M41.7M11.34M
Invested capital
000.20.180.52
Average receivables
2.64M12.85M14M8.81M5.06M
Average payables
4.22M3.61M4.4M7.14M7.03M
Average inventory
00000
Days sales outstanding
391.66257.78108.3890.080.64
Days payables outstanding
409.87333.021.65K00
Days of inventory on hand
00000
Receivables turnover
0.931.423.374.05574.31
Payables turnover
0.891.10.2200
Inventory turnover
00000
ROE
-0.35-0.59-1.22-1.04-1.29
Capex per share
-0.19-0.2-0.21-0.09-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q1

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.314.910.880.229.8
Net income per share
-2.571.54-2.17-1.518.46
Operating cash flow per share
-2.22-2.14-1.82-1.7-2.78
Free cash flow per share
-2.23-2.14-1.82-1.69-2.77
Cash per share
20.7718.6416.8115.1112.34
Book value per share
5.67.265.163.712.21
Tangible book value per share
5.67.265.163.712.21
Share holders equity per share
5.67.265.163.712.21
Interest debt per share
2.132.081.821.911.86
Market cap
51.97M31.98M30.65M43.84M46.71M
Enterprise value
51M34.44M34.89M39.66M55.72M
P/E ratio
-0.760.78-0.53-1.090.21
Price to sales ratio
5.950.985.230.090.72
POCF ratio
-3.52-2.24-2.53-3.88-2.53
PFCF ratio
-3.5-2.24-2.53-3.89-2.53
P/B Ratio
1.390.660.891.780.57
PTB ratio
1.390.660.891.780.57
EV to sales
5.841.055.9227.220.85
Enterprise value over EBITDA
-2.654.04-2.14-3.611.01
EV to operating cash flow
-3.45-2.41-2.88-3.51-3.01
EV to free cash flow
-3.44-2.41-2.88-3.52-3.01
Earnings yield
-0.330.32-0.47-0.231.21
Free cash flow yield
-0.29-0.45-0.4-0.26-0.4
Debt to equity
0.370.280.380.520.15
Debt to assets
0.080.090.10.110.12
Net debt to EBITDA
0.050.29-0.260.380.16
Current ratio
6.355.895.15.2910.32
Interest coverage
-37.9618.3717.2852.310
Income quality
0.89-1.390.791.13-0.33
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.860.261.226.840.1
Research and developement to revenue
2.230.472.561.760.05
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
-0.01000.020
Capex to depreciation
-0.64000.290.08
Stock based compensation to revenue
0.180.020.160.210.01
Graham number
17.9815.8515.8811.1948.21
ROIC
-0.290.14-0.25-0.20.53
Return on tangible assets
-0.10.07-0.11-0.080.56
Graham Net
2.694.392.350.699.35
Working capital
125.47M110.79M96.86M87.19M79.86M
Tangible asset value
37.31M48.37M34.35M24.62M81.36M
Net current asset value
22.63M34.22M20.65M11.34M68.53M
Invested capital
0.370.280.380.520.15
Average receivables
8.9M6.73M5.14M2.33M42.5K
Average payables
8.17M6.24M4.23M5.26M4.68M
Average inventory
00000
Days sales outstanding
79.9815.6869.945.250
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
1.135.741.2917.140
Payables turnover
00000
Inventory turnover
00000
ROE
-0.460.21-0.42-0.410.69
Capex per share
-0.010000

MEIP Frequently Asked Questions

What is MEI Pharma, Inc. stock symbol ?

MEI Pharma, Inc. is a US stock , located in San diego of Ca and trading under the symbol MEIP

What is MEI Pharma, Inc. stock quote today ?

MEI Pharma, Inc. stock price is $6.72 today.

Is MEI Pharma, Inc. stock public?

Yes, MEI Pharma, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap